NO850444L - Fremgangsmaate for fremstilling av (-)-trans-4-(4-fluorfenyl)-3-(4-metoksyfenoksy)-metylperidin eller farmasoeytisk akseptable syreaddisjonssalter derav - Google Patents
Fremgangsmaate for fremstilling av (-)-trans-4-(4-fluorfenyl)-3-(4-metoksyfenoksy)-metylperidin eller farmasoeytisk akseptable syreaddisjonssalter deravInfo
- Publication number
- NO850444L NO850444L NO850444A NO850444A NO850444L NO 850444 L NO850444 L NO 850444L NO 850444 A NO850444 A NO 850444A NO 850444 A NO850444 A NO 850444A NO 850444 L NO850444 L NO 850444L
- Authority
- NO
- Norway
- Prior art keywords
- trans
- acid addition
- fluorophenyl
- compounds
- methylpiperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Liquid Crystal Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/577,844 US4585777A (en) | 1984-02-07 | 1984-02-07 | (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO850444L true NO850444L (no) | 1985-08-08 |
Family
ID=24310381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO850444A NO850444L (no) | 1984-02-07 | 1985-02-06 | Fremgangsmaate for fremstilling av (-)-trans-4-(4-fluorfenyl)-3-(4-metoksyfenoksy)-metylperidin eller farmasoeytisk akseptable syreaddisjonssalter derav |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4585777A (pm) |
| EP (1) | EP0152273B1 (pm) |
| JP (1) | JPS60181071A (pm) |
| AT (1) | ATE46146T1 (pm) |
| CA (1) | CA1246082A (pm) |
| DE (1) | DE3572807D1 (pm) |
| DK (1) | DK53285A (pm) |
| ES (1) | ES8601131A1 (pm) |
| FI (1) | FI850449A7 (pm) |
| GR (1) | GR850309B (pm) |
| IE (1) | IE850286L (pm) |
| NO (1) | NO850444L (pm) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0223334B1 (en) * | 1985-08-10 | 1991-07-10 | Beecham Group Plc | Process for the preparation of aryl-piperidine carbinols |
| IE66332B1 (en) * | 1986-11-03 | 1995-12-27 | Novo Nordisk As | Piperidine compounds and their preparation and use |
| GB8626936D0 (en) * | 1986-11-11 | 1986-12-10 | Ferrosan As | Treatment |
| HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| GB9623359D0 (en) * | 1996-11-09 | 1997-01-08 | Smithkline Beecham Plc | Novel process |
| GB9700690D0 (en) | 1997-01-15 | 1997-03-05 | Smithkline Beecham Plc | Novel process |
| ATE279393T1 (de) | 1997-05-29 | 2004-10-15 | Smithkline Beecham Corp | Neues verfahren |
| AU2002301956B2 (en) * | 1997-06-10 | 2006-02-09 | Synthon B.V. | 4-phenylpiperidine compounds |
| EE03970B1 (et) * | 1997-06-10 | 2003-02-17 | Synthon B.V. | 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim |
| CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
| GB9914583D0 (en) * | 1999-06-22 | 1999-08-25 | Smithkline Beecham Plc | Novel process |
| WO2001085688A1 (en) | 2000-05-12 | 2001-11-15 | Synthon B.V. | TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS |
| AU2001270858A1 (en) * | 2000-07-17 | 2002-01-30 | Smithkline Beecham Plc | Novel processes for the preparation of 4-phenylpiperidine derivatives |
| AU2001211337A1 (en) * | 2000-10-06 | 2002-04-15 | Smithkline Beecham Plc | Process for the preparation of aryl-piperidine carbinols and intermediates thereof |
| US6777554B2 (en) | 2001-02-05 | 2004-08-17 | Teva Pharmaceutical Industries Ltd. | Preparation of N-methylparoxetine and related intermediate compounds |
| NL1017421C2 (nl) | 2001-02-21 | 2002-01-15 | Synthon Bv | Werkwijze voor het vervaardigen van paroxetine. |
| EP1406624A4 (en) | 2001-06-13 | 2005-03-30 | Teva Pharma | METHOD FOR PRODUCING PAROXETIN, WHICH IS ESPECIALLY FREE OF ALKOXY POLLUTION |
| US20070142389A1 (en) * | 2005-12-20 | 2007-06-21 | Pfizer Inc. | Piperidine derivatives |
| CN101855218A (zh) | 2007-09-13 | 2010-10-06 | 康塞特医药品有限公司 | 氘化的儿茶酚和苯并[d][1,3]间二氧杂环戊烯及其衍生物的合成 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
-
1984
- 1984-02-07 US US06/577,844 patent/US4585777A/en not_active Expired - Lifetime
-
1985
- 1985-01-07 CA CA000471622A patent/CA1246082A/en not_active Expired
- 1985-02-04 GR GR850309A patent/GR850309B/el unknown
- 1985-02-04 FI FI850449A patent/FI850449A7/fi not_active Application Discontinuation
- 1985-02-06 AT AT85300793T patent/ATE46146T1/de not_active IP Right Cessation
- 1985-02-06 DK DK53285A patent/DK53285A/da not_active Application Discontinuation
- 1985-02-06 ES ES540172A patent/ES8601131A1/es not_active Expired
- 1985-02-06 DE DE8585300793T patent/DE3572807D1/de not_active Expired
- 1985-02-06 EP EP85300793A patent/EP0152273B1/en not_active Expired
- 1985-02-06 IE IE850286A patent/IE850286L/xx unknown
- 1985-02-06 JP JP60020218A patent/JPS60181071A/ja active Granted
- 1985-02-06 NO NO850444A patent/NO850444L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0152273B1 (en) | 1989-09-06 |
| EP0152273A2 (en) | 1985-08-21 |
| CA1246082A (en) | 1988-12-06 |
| EP0152273A3 (en) | 1986-12-30 |
| GR850309B (pm) | 1985-06-05 |
| ES540172A0 (es) | 1985-11-16 |
| FI850449L (fi) | 1985-08-08 |
| DK53285D0 (da) | 1985-02-06 |
| JPS6135176B2 (pm) | 1986-08-12 |
| IE850286L (en) | 1985-08-07 |
| JPS60181071A (ja) | 1985-09-14 |
| FI850449A0 (fi) | 1985-02-04 |
| ES8601131A1 (es) | 1985-11-16 |
| DE3572807D1 (en) | 1989-10-12 |
| FI850449A7 (fi) | 1985-08-08 |
| DK53285A (da) | 1985-08-08 |
| US4585777A (en) | 1986-04-29 |
| ATE46146T1 (de) | 1989-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO850444L (no) | Fremgangsmaate for fremstilling av (-)-trans-4-(4-fluorfenyl)-3-(4-metoksyfenoksy)-metylperidin eller farmasoeytisk akseptable syreaddisjonssalter derav | |
| AU693892B2 (en) | Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof | |
| JP3343256B2 (ja) | 新規な３，３−ジフェニルプロピルアミン類、その使用および製造法 | |
| US11723900B2 (en) | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds | |
| KR960015087B1 (ko) | 피페리딘 아편양 길항제, 이의 제조방법 및 이를 포함하는 약제학적 제형 | |
| JPS6254095B2 (pm) | ||
| NO329065B1 (no) | Derivater av N-[fenyl(piperidin-2yl)metyl]benzamid og anvendelse av de samme i terapeutika | |
| NO156690B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanderivater. | |
| US4960797A (en) | N-2[(4-fluoro-phenyl)-1-methyl]-2-ethyl-N-methyl-N-propynyl amine and the method of use thereof | |
| NO136094B (pm) | ||
| EP0004831B1 (en) | 2,6-dialkoxybenzamides, process for their preparation, compositions and these compounds for use in the treatment of psychotic disordes | |
| US5319087A (en) | Piperidine opioid antagonists | |
| JPH05509311A (ja) | １，４―二置換ピペラジン | |
| JPS6033424B2 (ja) | フェニルエチルアミンの誘導体、その製造方法およびフェニルエチルアミンの誘導体を有効成分とする高血圧および心臓血管病の治療薬 | |
| US4593036A (en) | (-)-Trans-4-(4-fluorophenyl)-3-[(4-methoxyphenoxy)methyl]-1-methylpiperidine useful as 5-HT potentiator | |
| CA2282840C (en) | S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist | |
| KR100707904B1 (ko) | 항히스타민 피페리딘 유도체 및 이를 제조하기 위한 중간체 | |
| JP2012501307A (ja) | ピペリジン−４−アセトアミド誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのその使用 | |
| NO138804B (no) | Analogifremgangsmaater til fremstilling av aminosyrederivater med antidepressiv virkning | |
| JP2525244B2 (ja) | （＋）１―〔（３，４，５―トリメトキシ）―ベンジルオキシメチル〕―１―フェニル―Ｎ，Ｎ―ジメチル―ｎ―プロピルアミン | |
| JP2012501306A (ja) | うつ病及びパニック障害を含むｃｎｓ障害の処置に有用なピペリジルプロピオンアミド誘導体 | |
| JP2011509967A (ja) | 新規なピペリジン−４−カルボン酸フェニル−アルキル−アミド誘導体及びモノアミン神経伝達物質再取り込み阻害薬としてのその使用 | |
| CA1109484A (en) | 2,6-dialkoxybenzamides, intermediates, pharmaceutical compositions and methods for treatment of psychotic disorders | |
| IE903418A1 (en) | (+)-(2-Hydroxy-2-adamantyl)-1-imidazolyl-3-tolymethane and¹the salts thereof, a process for the preparation thereof,¹pharmaceuticals containing this compound, and the use¹thereof | |
| NO118171B (pm) |